- Coronavirus protection drug approved by FDA for testing in Houston
KTRK ABC 13 - July 10, 2020 - Houston biotech company gets green light from FDA to test coronavirus-fighting drug
InnovationMap - May 2020 - Houston company testing drug to protect against COVID 19
KTRK-TV Houston - ABC 13 - May 2020 - Houston company working on possible COVID-19 treatment
Houston Fox 26 News - March 2020 - Houston biotech co.’s coronavirus treatment candidate to undergo clinical trials
Houston Business Journal - March 2020 - Houston researchers test lung inhalant that could protect healthcare workers from COVID-19
Houston Chronicle - March 2020 - Houston biopharmaceutical company brings on new CEO to grow company
InnovationMap - Oct 2019 - Pulmotect Seeks Quick-To-Market Path For Rapid-Acting Respiratory Drug
Scrip - June 2017 - Telephus Medical CEO Mark Benedyk Joins Pulmotect, Inc. Board of Directors
BioSpace - June 2017 - Pulmotect Convenes Inaugural Scientific Advisory Board
BioSpace - June 2017 - Biotech CEOs Bring Fresh Experience to Houston Ecosystem
Xconomy - April 2017 - Tour of Texas: Surge Ventures, Dell, Fannin Innovation, CellRight
Xconomy - April 2016 - Pulmotect Completes Second Clinical Trial, Obtains Funding
Pharmacy Choice - April 2016 - Synthetic inhaled drug prevents pneumonia in cancer patients
Scrip Pharma Intelligence - December 2015 - Texas Roundup: Pulmotect, Tech Wildcatters, Houston2035, & SynShark
Xconomy - June 2015 - Preventing airborne infection: Pulmotect arms the lungs with extra immunity
Med City News - Jun 1, 2015 - Houston biotech company receives $3 million
Houston Business Journal - May 2015 - Pulmotect Concludes Phase I Trial for Respiratory Infections Therapy
Bio News Texas - October 2014